Nektar Therapeutics’ (NKTR) “Market Perform” Rating Reaffirmed at William Blair
William Blair reiterated their market perform rating on shares of Nektar Therapeutics (NASDAQ:NKTR – Free Report) in a report issued on Tuesday,RTT News reports. Other research analysts have also ...
William Blair Keeps Their Hold Rating on Lantheus (LNTH)
William Blair analyst Andy Hsieh reiterated a Hold rating on Lantheus (LNTH – Research Report) today. The company’s shares opened today at ...
UBS Sticks to Its Hold Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)
In a report released today, Graham Doyle from UBS maintained a Hold rating on Fresenius Medical Care AG & Co. KGaA (0H9X – Research ...
US close: Stocks mixed as weak consumer confidence, tariff fears weigh on stocks
Major indices turned in a mixed performance on Tuesday as falling consumer confidence and tariff-related fears both continue to weigh on stocks.